Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.
about
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term efficacy of modified ...... trolled, dose-selection study.
@en
Long-term efficacy of modified ...... trolled, dose-selection study.
@nl
type
label
Long-term efficacy of modified ...... trolled, dose-selection study.
@en
Long-term efficacy of modified ...... trolled, dose-selection study.
@nl
prefLabel
Long-term efficacy of modified ...... trolled, dose-selection study.
@en
Long-term efficacy of modified ...... trolled, dose-selection study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Long-term efficacy of modified ...... ntrolled, dose-selection study
@en
P2093
Albert Driedger
Aldo Pinchera
Annie Purvis
Christian Düren
Christoph Reiners
Christopher Marriott
Dyde A Huysmans
Emmanuelle Proust-Lemoine
Furio Pacini
P2860
P304
P356
10.1089/THY.2013.0370
P577
2014-03-04T00:00:00Z